252 related articles for article (PubMed ID: 33524943)
1. Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review.
Wang JL; Scheitler KM; Wenger NM; Elder JB
Neurosurg Focus; 2021 Feb; 50(2):E2. PubMed ID: 33524943
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
Hervás-Corpión I; Alonso MM
Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report.
Lu VM; Shah AH; Vallejo FA; Eichberg DG; Luther EM; Shah SS; Komotar RJ; Ivan ME
Neurosurg Focus; 2021 Feb; 50(2):E3. PubMed ID: 33524946
[TBL] [Abstract][Full Text] [Related]
4. Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II).
Giotta Lucifero A; Luzzi S
Brain Sci; 2021 Jul; 11(8):. PubMed ID: 34439595
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
Asija S; Chatterjee A; Goda JS; Yadav S; Chekuri G; Purwar R
Front Immunol; 2023; 14():1118246. PubMed ID: 37006286
[TBL] [Abstract][Full Text] [Related]
6. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.
Zhang Q; Liu F
Cell Death Dis; 2020 Jun; 11(6):485. PubMed ID: 32587256
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice.
Shoaf ML; Desjardins A
Neurotherapeutics; 2022 Oct; 19(6):1818-1831. PubMed ID: 35674873
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application.
Hua L; Wakimoto H
Expert Opin Biol Ther; 2019 Aug; 19(8):845-854. PubMed ID: 31046478
[TBL] [Abstract][Full Text] [Related]
9. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.
Omar NB; Bentley RT; Crossman DK; Foote JB; Koehler JW; Markert JM; Platt SR; Rissi DR; Shores A; Sorjonen D; Yanke AB; Gillespie GY; Chambers MR
Neurosurg Focus; 2021 Feb; 50(2):E5. PubMed ID: 33524948
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Suryawanshi YR; Schulze AJ
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
[TBL] [Abstract][Full Text] [Related]
11. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
[TBL] [Abstract][Full Text] [Related]
12. From Bench to Bedside, the Current State of Oncolytic Virotherapy in Pediatric Glioma.
Soldozy S; Skaff A; Soldozy K; Sokolowski JD; Norat P; Yagmurlu K; Sharifi KA; Tvrdik P; Park MS; Kalani MYS; Jane JA; Syed HR
Neurosurgery; 2020 Nov; 87(6):1091-1097. PubMed ID: 32542365
[TBL] [Abstract][Full Text] [Related]
13. Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.
Hu M; Liao X; Tao Y; Chen Y
Front Immunol; 2023; 14():1285113. PubMed ID: 38022620
[TBL] [Abstract][Full Text] [Related]
14. [Oncolytic viruses for therapy of malignant glioma].
Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery.
Romanishin A; Vasilev A; Khasanshin E; Evtekhov A; Pusynin E; Rubina K; Kakotkin V; Agapov M; Semina E
Virology; 2024 May; 593():110033. PubMed ID: 38442508
[TBL] [Abstract][Full Text] [Related]
16. Gene therapies for high-grade gliomas: from the bench to the bedside.
Giotta Lucifero A; Luzzi S; Brambilla I; Guarracino C; Mosconi M; Foiadelli T; Savasta S
Acta Biomed; 2020 Jun; 91(7-S):32-50. PubMed ID: 32608374
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
18. Promises of oncolytic viral therapy for adult and children with brain glioma.
Patiño-García A; Alonso MM; Gállego Pérez-Larraya J
Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087
[TBL] [Abstract][Full Text] [Related]
19. The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.
Cuoco JA; Rogers CM; Mittal S
Neurosurg Focus; 2021 Feb; 50(2):E8. PubMed ID: 33524945
[TBL] [Abstract][Full Text] [Related]
20. [Oncolytic viruses in the therapy of gliomas].
Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
